Benzinga | Mar 17, 2021 07:07PM EDT

Precigen Received FDA Orphan Drug Designation for Adenoviral Vector Expressing HPV 6 and HPV 11 Antigens for Treatment of Recurrent Respiratory Papillomatosis

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=805520